Search research articles
Contact Us
Filters
Showing results (221-230 of 331) with videos related to
Page
of 34
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 26, 2005
Postoperative radiation therapy for grade II and III intracranial ependymoma
David B Mansur, Arie Perry, Veena Rajaram, et al.
The Journal of Urology
|
March 14, 2022
Reply by Authors
Neal Andruska, Benjamin W Fischer-Valuck, Michael Waters, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
Deborah A Kuban, Howard D Thames, Larry B Levy, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2000
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
A Cacciapuoti, D Loebenberg, E Corcoran, et al.
Cancer
|
September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
Eric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
Mary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.
European Urology Oncology
|
May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
Shauna R Campbell, Martin C Tom, Shree Agrawal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
Michael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer
|
March 22, 2017
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621
Mark D Hurwitz, Jonathan Harris, Oliver Sartor, et al.
Clinical Genitourinary Cancer
|
September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Page
of 34
Search research articles
Search
Showing results (221-230 of 331) with videos related to
Sort By:
Page
of 34
International Journal of Radiation Oncology, Biology, Physics
|
January 26, 2005
Postoperative radiation therapy for grade II and III intracranial ependymoma
David B Mansur, Arie Perry, Veena Rajaram, et al.
The Journal of Urology
|
March 14, 2022
Reply by Authors
Neal Andruska, Benjamin W Fischer-Valuck, Michael Waters, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2003
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era
Deborah A Kuban, Howard D Thames, Larry B Levy, et al.
Antimicrobial Agents and Chemotherapy
|
July 18, 2000
In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida
A Cacciapuoti, D Loebenberg, E Corcoran, et al.
Cancer
|
September 1, 2006
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysis
Eric M Horwitz, Lawrence B Levy, Howard D Thames, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2007
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy
Mary Feng, Alexandra L Hanlon, Thomas M Pisansky, et al.
European Urology Oncology
|
May 21, 2021
Integrating Prostate-specific Antigen Kinetics into Contemporary Predictive Nomograms of Salvage Radiotherapy After Radical Prostatectomy
Shauna R Campbell, Martin C Tom, Shree Agrawal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 4, 2005
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis
Michael E Ray, Howard D Thames, Larry B Levy, et al.
Cancer
|
March 22, 2017
Adjuvant radiation therapy, androgen deprivation, and docetaxel for high-risk prostate cancer postprostatectomy: Results of NRG Oncology/RTOG study 0621
Mark D Hurwitz, Jonathan Harris, Oliver Sartor, et al.
Clinical Genitourinary Cancer
|
September 13, 2023
Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?
Neal Andruska, Michael R Waters, Benjamin W Fischer-Valuck, et al.
Page
of 34